These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 15725808)
21. Cholangiocarcinoma arising in bile duct adenoma with focal area of bile duct hamartoma. Hasebe T; Sakamoto M; Mukai K; Kawano N; Konishi M; Ryu M; Fukamachi S; Hirohashi S Virchows Arch; 1995; 426(2):209-13. PubMed ID: 7757293 [TBL] [Abstract][Full Text] [Related]
23. Adenocarcinomas metastatic to the liver: the value of cytokeratins 20 and 7 in the search for unknown primary tumors. Tot T Cancer; 1999 Jan; 85(1):171-7. PubMed ID: 9921990 [TBL] [Abstract][Full Text] [Related]
24. Dpc4 protein in mucinous cystic neoplasms of the pancreas: frequent loss of expression in invasive carcinomas suggests a role in genetic progression. Iacobuzio-Donahue CA; Wilentz RE; Argani P; Yeo CJ; Cameron JL; Kern SE; Hruban RH Am J Surg Pathol; 2000 Nov; 24(11):1544-8. PubMed ID: 11075857 [TBL] [Abstract][Full Text] [Related]
25. Analysis of novel tumor markers in pancreatic and biliary carcinomas using tissue microarrays. Swierczynski SL; Maitra A; Abraham SC; Iacobuzio-Donahue CA; Ashfaq R; Cameron JL; Schulick RD; Yeo CJ; Rahman A; Hinkle DA; Hruban RH; Argani P Hum Pathol; 2004 Mar; 35(3):357-66. PubMed ID: 15017593 [TBL] [Abstract][Full Text] [Related]
26. Novel immunohistochemical markers differentiate intrahepatic cholangiocarcinoma from benign bile duct lesions. Bertram S; Padden J; Kälsch J; Ahrens M; Pott L; Canbay A; Weber F; Fingas C; Hoffmann AC; Vietor A; Schlaak JF; Eisenacher M; Reis H; Sitek B; Baba HA J Clin Pathol; 2016 Jul; 69(7):619-26. PubMed ID: 26729014 [TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2. Chu PG; Schwarz RE; Lau SK; Yen Y; Weiss LM Am J Surg Pathol; 2005 Mar; 29(3):359-67. PubMed ID: 15725805 [TBL] [Abstract][Full Text] [Related]
28. Comparative immunohistochemical study of primary and metastatic carcinomas of the liver. Ma CK; Zarbo RJ; Frierson HF; Lee MW Am J Clin Pathol; 1993 May; 99(5):551-7. PubMed ID: 7684185 [TBL] [Abstract][Full Text] [Related]
29. Expression of cytokeratin 20 in mucinous bronchioloalveolar carcinoma. Shah RN; Badve S; Papreddy K; Schindler S; Laskin WB; Yeldandi AV Hum Pathol; 2002 Sep; 33(9):915-20. PubMed ID: 12378517 [TBL] [Abstract][Full Text] [Related]
30. Intrahepatic Cholangiocarcinoma Coexisting With Multiple Bile Duct Adenoma Treated as Liver Metastasis from a Pancreatic Neuroendocrine Tumor. Oda E; Yamamura K; Hara Y; Matsumura K; Akahoshi S; Yuki H; Motohara T; Miyamoto H; Kinoshita K; Matsumura F; Ohnishi K; Komohara Y; Beppu T Anticancer Res; 2021 Oct; 41(10):5249-5254. PubMed ID: 34593478 [TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical labeling for the Dpc4 gene product is a specific marker for adenocarcinoma in biopsy specimens of the pancreas and bile duct. Tascilar M; Offerhaus GJ; Altink R; Argani P; Sohn TA; Yeo CJ; Cameron JL; Goggins M; Hruban RH; Wilentz RE Am J Clin Pathol; 2001 Dec; 116(6):831-7. PubMed ID: 11764071 [TBL] [Abstract][Full Text] [Related]
32. Utility of MMP-1, p53, E-cadherin, and collagen IV immunohistochemical stains in the differential diagnosis of adenomas with misplaced epithelium versus adenomas with invasive adenocarcinoma. Yantiss RK; Bosenberg MW; Antonioli DA; Odze RD Am J Surg Pathol; 2002 Feb; 26(2):206-15. PubMed ID: 11812942 [TBL] [Abstract][Full Text] [Related]
33. Differing rates of loss of DPC4 expression and of p53 overexpression among carcinomas of the proximal and distal bile ducts. Argani P; Shaukat A; Kaushal M; Wilentz RE; Su GH; Sohn TA; Yeo CJ; Cameron JL; Kern SE; Hruban RH Cancer; 2001 Apr; 91(7):1332-41. PubMed ID: 11283934 [TBL] [Abstract][Full Text] [Related]
34. The novel monoclonal antibody HPC2 and N-cadherin distinguish pancreatic ductal adenocarcinoma from cholangiocarcinoma. Hooper JE; Morgan TK; Grompe M; Sheppard BC; Troxell ML; Corless CL; Streeter PR Hum Pathol; 2012 Oct; 43(10):1583-9. PubMed ID: 22406361 [TBL] [Abstract][Full Text] [Related]
35. Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray. Maitra A; Adsay NV; Argani P; Iacobuzio-Donahue C; De Marzo A; Cameron JL; Yeo CJ; Hruban RH Mod Pathol; 2003 Sep; 16(9):902-12. PubMed ID: 13679454 [TBL] [Abstract][Full Text] [Related]
36. Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE). Argani P; Iacobuzio-Donahue C; Ryu B; Rosty C; Goggins M; Wilentz RE; Murugesan SR; Leach SD; Jaffee E; Yeo CJ; Cameron JL; Kern SE; Hruban RH Clin Cancer Res; 2001 Dec; 7(12):3862-8. PubMed ID: 11751476 [TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma. Wang HL; Lu DW; Yerian LM; Alsikafi N; Steinberg G; Hart J; Yang XJ Am J Surg Pathol; 2001 Nov; 25(11):1380-7. PubMed ID: 11684954 [TBL] [Abstract][Full Text] [Related]
38. The relationship between loss expression of DPC4/Smad4 gene and carcinogenesis of pancreatobiliary carcinoma. Tang ZH; Zou SQ; Hao YH; Wang BJ; Yang XP; Chen QQ; Qiu FZ Hepatobiliary Pancreat Dis Int; 2002 Nov; 1(4):624-9. PubMed ID: 14607700 [TBL] [Abstract][Full Text] [Related]
39. Role of TTF-1, CK20, and CK7 immunohistochemistry for diagnosis of primary and secondary lung adenocarcinoma. Su YC; Hsu YC; Chai CY Kaohsiung J Med Sci; 2006 Jan; 22(1):14-9. PubMed ID: 16570563 [TBL] [Abstract][Full Text] [Related]
40. [Expression of mucin glycoproteins and cytokeratins in intrahepatic cholangiocarcinoma]. Zhao SM; Zhu XZ; Ji Y; Hou J Zhonghua Bing Li Xue Za Zhi; 2008 Nov; 37(11):749-53. PubMed ID: 19094709 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]